Acute infantile pneumonopathies treated with fosfomycin.

Abstract:

:Reference is made to the results obtained in 24 children, from 11 months to 12 years, affected with acute pneumopathies and treated with fosfomycin with a dosage of 200 mg/kg/day. In all cases a clinical, radiological, biological and bacteriological study was carried out. At the same time, levels of fosfomycin in plasma and sputum were checked every 5 days during the course of treatment. In the 4 cases of pleurisy the level of antibiotic in the pleural liquid was also checked. The concentration of fosfomycin in the sputum gives very variable results with average values oscillating between 16.5 and 23.4% of the plasmatic level respectively at the beginning and end of treatment, a cumulative effect of the antibiotic being observed. Concentration in pleural liquid oscillates between 39 and 50%. The clinical, radiological and biological evolution has been favourable iin 21 cases, unfavourable in two cases and in one case treatment had to be suspended because of the apparition of a cutaneous necrosis. Apart from this case no notable toxic effects were observed. Children do not support intramuscular injections very well and intravenous injections often cause phlebitis.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Llorens J,Ley G,Forés A,Olay T

doi

10.1159/000222069

subject

Has Abstract

pub_date

1977-01-01 00:00:00

pages

315-23

eissn

0009-3157

issn

1421-9794

journal_volume

23 Suppl 1

pub_type

杂志文章
  • Fluoropyrimidine-Associated Toxicity in Two Gastrointestinal Cancer Patients: Potential Role of Common DPYD Polymorphisms.

    abstract::While the majority of patients can be treated safely with fluoropyrimidine, some experience severe fluoropyrimidine-associated toxicity. The frequency and severity of these adverse events vary from patient to patient and are partially explained by genetic polymorphism into the dihydropyrimidine dehydrogenase (DPYD) ge...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000477333

    authors: Falvella FS,Luoni M,Cheli S,Fava S,Cergnul M

    更新日期:2017-01-01 00:00:00

  • Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.

    abstract:BACKGROUND:Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithelial ovarian cancer (EOC). Yet, there is a wide variety in clinical practice. METHODS:All patients diagnosed with FIGO I and IIa EOC (2006-2010) in the south of the Netherlands were analyzed. The percentage of patients th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000445024

    authors: Frielink LM,Pijlman BM,Ezendam NP,Pijnenborg JM

    更新日期:2016-01-01 00:00:00

  • Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.

    abstract::The intracellular activity of flurithromycin, erythromycin, roxithromycin and miocamycin against susceptible clinical isolates of Staphylococcus aureus, phagocytosed by human monocytes, was investigated. Intracellular bioactivity was studied in a 24-hour assay, using experimental conditions which allowed the intracell...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238973

    authors: Fietta A,Boeri P,Colombo ML,Merlini C,Gialdroni Grassi G

    更新日期:1993-01-01 00:00:00

  • Cefixime for switch therapy.

    abstract::Switch therapy, or step-down therapy, is the concept of switching from an intravenous antibiotic to an oral preparation after a few days, once the condition of the patient has improved and the pathogen and its susceptibility have been determined. The orally active third-generation cephalosporin cefixime is a primary c...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048460

    authors: Hamilton-Miller J

    更新日期:1998-09-01 00:00:00

  • The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.

    abstract:BACKGROUND:We evaluated the effectiveness of docetaxel or erlotinib in second-line treatment of non-small cell lung cancer (NSCLC) and focused on the impact of predictive factors on the outcome of therapy. METHODS:204 patients with progressive disease after platinum-based therapy were enrolled: 102 received an infusio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000336143

    authors: Krawczyk P,Kowalski DM,Wojas-Krawczyk K,Mlak R,Jaśkiewicz P,Kucharczyk T,Winiarczyk K,Krzakowski M,Milanowski J

    更新日期:2012-01-01 00:00:00

  • In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.

    abstract::The in vitro activity of the new semisynthetic ureidopenicillins azlocillin (AZ) and mezlocillin (MZ), and of the new cephalosporin cefsulodin (CEF) were determined against 50 carbenicillin-sensitive (CARs) and 50 carbenicillin-resistant (CARr) P. aeruginosa clinical isolates. In the CARs group the most active antibio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237918

    authors: Perea EJ,Palomares JC,García-Iglesias MC

    更新日期:1980-01-01 00:00:00

  • In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.

    abstract::The in vitro susceptibilities of 703 clinical isolates of Salmonella to ciprofloxacin (CIP) and pefloxacin (PEF) were compared with those to trimethoprim-sulfamethoxazole (TMP-SMZ), chloramphenicol (CO) and ampicillin (AP). All isolates were susceptible to CIP, while PEF inhibited 90.7% of the strains. In contrast, re...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238745

    authors: Campos LC,dos Reis EM,Ribeiro Dias JC

    更新日期:1990-01-01 00:00:00

  • Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruzi.

    abstract::Eight thiadiazine 1,1-dioxide derivatives were evaluated for antitrichomonal and antitrypanosomal activities. In vivo tests were performed on a murine model for trichomoniasis standardized in our laboratory. The capacity of compounds to clear visceral lesions in experimentally infected animals as well as their effects...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239040

    authors: Atienza J,Martínez Díaz RA,Gómez Barrio A,Escario JA,Herrero A,Ochoa C,Rodríguez J

    更新日期:1992-01-01 00:00:00

  • Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    abstract:BACKGROUNDS:The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma (BTC). However, this is only based on phase II studies performed in selected patients.We assessed the efficacy and safety of the GEMOX regimen in non-selected patients with advanced BTC. MET...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000316848

    authors: Hollebecque A,Bouché O,Romano O,Scaglia E,Cattan S,Zerbib P,Heurgue A,Lagarde S,Mariette C,Triboulet JP,Pruvot FR,Hebbar M

    更新日期:2010-01-01 00:00:00

  • Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase.

    abstract:BACKGROUND:Some new quinolones (NQs) modulate polymorphonuclear leukocyte (PMN) functions. We investigated these effects on PMN functions at concentrations <10 microg/ml. METHODS:Chemotactic activity and the production of reactive oxygen species (ROS) were measured using a 48-well chemotaxis chamber and by luminol-dep...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000232451

    authors: Koshio O,Ono Y

    更新日期:2009-01-01 00:00:00

  • Serum and tissue tinidazole concentrations after intravenous infusion.

    abstract::Before appendectomy 36 adult patients were given an intravenous infusion of 500 mg of tinidazole. In the operation tissue samples were taken (blood, base of appendix vermiformis, muscle, fat) either 10, 20, 30, 60, or 120 min after cessation of infusion. The tinidazole concentrations were determined by liquid chromato...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238167

    authors: Viitanen J,Auvinen O,Tunturi T

    更新日期:1983-01-01 00:00:00

  • Comparative antibacterial activity of the penem ALP 201.

    abstract::The minimum inhibitory concentration (MIC) of the new penem ALP 201 was tested against 243 recent clinical isolates of which 95 were from the family Enterobacteriaceae, 50 were from the genus Streptococcus, 50 were Staphylococcus aureus and 48 were Staphylococcus epidermidis. An agar dilution technique was used to det...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238888

    authors: Bergan T,da Fonseca J

    更新日期:1991-01-01 00:00:00

  • A retrospective study of the novel combination of paclitaxel and S1 for pretreated advanced non-small cell lung cancer.

    abstract:BACKGROUND:Recently, multiple-line chemotherapy has become popular for non-small cell lung cancer (NSCLC). The survival time of patients is influenced by patient characteristics and subsequent treatments. METHODS:The usefulness of paclitaxel plus S1 (PTX+S1) was evaluated in 46 pretreated NSCLC patients. Time from the...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000345624

    authors: Aono N,Ito Y,Nishino K,Uchida J,Kumagai T,Akazawa Y,Okuyama T,Yoshinami T,Imamura F

    更新日期:2012-01-01 00:00:00

  • The effect of erythromycin on the growth of Rickettsia prowazekii in the body louse (Pediculus humanus corporis L) and the tick (Ornithodoros moubata Murray).

    abstract::Body lice (Pediculus humanus corporis L) and ticks (Ornithodoros moubata) that had been infected with Rickettsia prowazekii received varying doses of erythromycin. The anti-rickettsial activity of this drug was evaluated with regard to the determination of the numbers of surviving microorganism (LID100) and the in viv...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221910

    authors: Becla E

    更新日期:1976-01-01 00:00:00

  • Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin.

    abstract:BACKGROUND:Viscum album (VA) Qu FrF preparation consists of an aqueous extract of Viscum album, the European mistletoe. It has cytotoxic and immunomodulatory properties that support its usefulness in cancer therapy. However, only little information is available on the interaction between mistletoe lectin (ML) and the h...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048545

    authors: Duong Van Huyen JP,Sooryanarayana,Delignat S,Bloch MF,Kazatchkine MD,Kaveri SV

    更新日期:2001-09-01 00:00:00

  • Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.

    abstract:BACKGROUND:An ethylacetate-soluble fraction (ET4) from the lichen Ramalina farinacea has previously been shown to inhibit the infectivity of lentiviral and adenoviral vectors, as well as wild-type HIV-1. We now determined the antiviral activity of ET4 against other wild-type viruses, including the herpes simplex virus ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000194974

    authors: Esimone CO,Grunwald T,Nworu CS,Kuate S,Proksch P,Uberla K

    更新日期:2009-01-01 00:00:00

  • High teicoplanin uptake by human neutrophils.

    abstract::The cellular/extracellular (C/E) concentration ratio of teicoplanin in polymorphonuclear leukocytes (PMNs) increased rapidly with time (C/E 60 +/- 13 at 20 min). The C/E ratio was time- and concentration-dependent. At 20 min and an initial concentration of 75 +/- 16 micrograms/ml the cellular drug concentration was 4,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238576

    authors: Maderazo EG,Breaux SP,Woronick CL,Quintiliani R,Nightingale CH

    更新日期:1988-01-01 00:00:00

  • Examination of a novel, specified local antibiotic therapy through polymethylmethacrylate capsules in a rabbit osteomyelitis model.

    abstract::Chronic bone and soft tissue suppurations have become more frequent recently due to the increasing number of high-energy injuries. There are certain antibiotic beads available for local administration, but they cannot always be applied specifically against the pyogenic microorganisms. In the present study, a new techn...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000092371

    authors: Börzsei L,Mintál T,Koós Z,Kocsis B,Helyes Z,Kereskai L,Nyárády J

    更新日期:2006-01-01 00:00:00

  • Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.

    abstract::Using the biophotometer with ticarcillin no persistent bactericidal effect was found against Pseudomonas aeruginosa NCTC 10490. After addition of 1.2 microgram/ml gentamicin an increase of multiplication of bacteria was observed, but not after 1.2 microgram/ml tobramycin. With 6.2 microgram/ml tobramycin bactericidal ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222001

    authors: Ullmann U

    更新日期:1977-01-01 00:00:00

  • Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.

    abstract:BACKGROUND:This study was designed to examine the efficacy and compliance of S-1 for the patients with peritoneal metastasis of gastric cancer. METHODS:Sixteen consecutive patients with peritoneal metastasis of gastric cancer were treated with S-1. Their survival was compared with that of the historical control group ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000096002

    authors: Ishizone S,Maruta F,Saito H,Koide N,Sugiyama A,Nakayama J,Miyagawa S

    更新日期:2006-01-01 00:00:00

  • Studies on the phagocytic activity of human and rat polymorphonuclear cells exposed to doxycycline in vivo.

    abstract::Studies are presented on the in vitro phagocytic activity of rat and human polymorphonuclear leukocytes exposed in vivo to therapeutic concentrations of doxycycline. A 32P-labelled strain of Escherichia coli served as test microbe. No significant reduction of ingestion was observed although untreated AB leukocytes tes...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238015

    authors: Melby K,Midtvedt T

    更新日期:1981-01-01 00:00:00

  • Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.

    abstract::After intravenous bolus injection of single doses of 25, 50, 75 and 100 mg of ofloxacin (HOE 280) to 34 healthy male volunteers, concentrations of unchanged drug were estimated at various times in serum and urine over 32 and 48 h. Ofloxacin concentrations were determined using high-pressure liquid chromatography (HPLC...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238567

    authors: Verho M,Korn A,Badian M,Malerczyk V,Waldhäusl W

    更新日期:1988-01-01 00:00:00

  • Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.

    abstract::The in vitro activity of ceftazidime has been compared with those of cephalothin, cefuroxime, and netilmicin against a variety of gram-positive and gram-negative bacteria in order to register sensitivity patterns in the western part of Norway. An agar dilution method was used for minimal inhibitory concentration (MIC)...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238256

    authors: Digranes A,Dibb WL,Benonisen E

    更新日期:1984-01-01 00:00:00

  • Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.

    abstract::100 febrile patients with chemotherapy-induced neutropenia (less than 0.5 x 10(9)/l) were empirically treated by ceftriaxone (2 g daily in adults, 50 mg/kg daily in children, as a once daily injection) and amikacin (15-20 mg/kg daily). The mean age was 41 years (range 8-72). 51 patients had acute leukemia, 29 non-Hodg...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238883

    authors: Blanc C,Pollet JP,Bauters F

    更新日期:1991-01-01 00:00:00

  • Role of vitamin A in prevention and treatment of sarcoma 180 in mice.

    abstract::The effect of deficiency of vitamin A and its supplementation on growth of murine sarcoma 180 was evaluated. The efficacy of cyclophosphamide under depleted and supplemented condition of the vitamin was also scrutinized. Supplemental vitamin A helped to check progression of tumour growth and also increased the effecti...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238497

    authors: Ghosh J,Das S

    更新日期:1987-01-01 00:00:00

  • Effects of isoniazid on viability, cell morphologies and acid fastness properties of Mycobacterium avium NCTC 8559 during the growth cycle.

    abstract::Our previous study demonstrated that the effects of isoniazid (INH) on Mycobacterium tuberculosis at the cellular level varied according to the growth phases. In this study, the variations in the INH action on M. avium strain NCTC 8559 are reported. M. avium cells grown on Middlebrook 7H10 agar were harvested at diffe...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000104470

    authors: Mohamad S,Ibrahim P,Wahab HA

    更新日期:2007-01-01 00:00:00

  • Changes in serum erythropoietin levels during chemotherapy for lung cancer.

    abstract::Serial serum erythropoietin (EPO) levels were measured in 12 adult lung cancer patients during cancer chemotherapy. In major cases, EPO levels increased significantly after chemotherapy while the hemoglobin (Hb) remained at initial levels. EPO fell gradually or rapidly to initial levels after a peak, although the pati...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239014

    authors: Saijo Y,Nakai Y,Saito J,Sugawara S,Suzuki S,Numata Y,Motomiya M

    更新日期:1992-01-01 00:00:00

  • In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.

    abstract:BACKGROUND:Combination antimicrobial therapy is often necessary to eradicate infections caused by gram-negative bacteria. METHODS:To evaluate the potential benefit of aztreonam and fluoroquinolone combination therapy, the activity of aztreonam in combination with ciprofloxacin, gatifloxacin, levofloxacin and moxifloxa...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000069786

    authors: Critchley IA,Sahm DF,Kelly LJ,Karlowsky JA

    更新日期:2003-05-01 00:00:00

  • Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

    abstract::The pharmacokinetics of ceftriaxone (CRO) after subcutaneous and intravenous administration was studied in 10 healthy volunteers (5 males, 5 females, age 22-43 years, body weight 64.3 +/- 9.5 kg). Each of them received 2.0 g CRO i.v., and then 0.5 g i.v. and 0.5 g CRO s.c. in a randomized cross-over design. Subcutaneo...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238342

    authors: Borner K,Lode H,Hampel B,Pfeuffer M,Koeppe P

    更新日期:1985-01-01 00:00:00

  • Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.

    abstract::Resistant variants of three clinical Pseudomonas aeruginosa isolates were obtained in the presence of aztreonam. The variants exhibited a four- to eightfold increase in the minimal inhibitory concentrations to beta-lactam antibiotics (except imipenem) to quinolones, such as norfloxacin and fleroxacin, chloramphenicol ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238946

    authors: Leying HJ,Büscher KH,Cullmann W,Then RL

    更新日期:1992-01-01 00:00:00